News tagged with gene t
Researchers find that two antagonistic proteins help keep leukemia at bay, pointing to new potential treatments
Two proteins that scientists once thought carried out the same functions are actually antagonists of each other, and keeping them in balance is key to preventing diseases such as cancer, according to new findings published ...
Cancer
Feb 27, 2013 |
5 / 5 (1) |
0
|
Immune cells engineered in lab to resist HIV infection
Researchers at the Stanford University School of Medicine have found a novel way to engineer key cells of the immune system so they remain resistant to infection with HIV, the virus that causes AIDS.
HIV & AIDS
Jan 22, 2013 |
5 / 5 (4) |
0
|
New anti-tumor cell therapy strategies are more effective
Targeted T-cells can seek out and destroy tumor cells that carry specific antigen markers. Two novel anti-tumor therapies that take advantage of this T-cell response are described in articles published in Human Gene Therapy, a peer ...
Cancer
Oct 25, 2012 |
not rated yet |
0
Research could lead to new ways to ID women who have higher risk of breast cancer from low-dose radiation
(Medical Xpress)—Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) have identified tissue mechanisms that may influence a woman's susceptibility or resistance ...
Cancer
Oct 16, 2012 |
not rated yet |
0
|
Genetically engineering immune systems to fight melanoma: Clinical trial launched
Loyola University Medical Center has launched the first clinical trial in the Midwest of an experimental melanoma treatment that genetically engineers a patient's immune system to fight the deadly cancer.
Cancer
Oct 01, 2012 |
5 / 5 (1) |
0
Researchers determine how inflammatory cells function, setting stage for future remedies
A research team led by investigators at New York University and NYU School of Medicine has determined how cells that cause inflammatory ailments, such as Crohn's disease, multiple sclerosis, and arthritis, differentiate from ...
Inflammatory disorders
Sep 26, 2012 |
not rated yet |
0
|
Researchers identify possible key to slow progression toward AIDS
One of the big mysteries of AIDS is why some HIV-positive people take more than a decade to progress to full-blown AIDS, if they progress at all.
HIV & AIDS
Sep 19, 2012 |
5 / 5 (1) |
0
|
Inflammation drives Crohn's disease, says study
Inflammation -- not genetic susceptibility -- drives the growth of intestinal bacteria and invasive E. coli linked to Crohn's disease (CD), reports a new Cornell study.
Diseases, Conditions, Syndromes
Aug 16, 2012 |
5 / 5 (3) |
0
|
Scientists link 'oncometabolite' to onset of acute myeloid leukemia
A team of international scientists led by principal investigator Dr. Tak Mak at the Princess Margaret Cancer Centre, University Health Network, has identified a causative link between the product of a mutated metabolic enzyme ...
Cancer
Jul 04, 2012 |
5 / 5 (3) |
0
|
Gene therapy can correct forms of severe combined immunodeficiency
Severe combined immunodeficiency is defect in the immune system that results in a loss of the adaptive immune cells known as B cells and T cells. Mutations in several different genes can lead to the development of severe ...
Immunology
May 24, 2012 |
not rated yet |
0
Finnish researchers identify the cause for LGL leukemia
Researchers of the University of Helsinki, Helsinki University Central Hospital and Institute for Molecular Medicine Finland, have discovered that a mutation in the STAT3 gene is an underlying cause for LGL leukemia. Since ...
Cancer
May 16, 2012 |
not rated yet |
0
Predicting cancer relapse: Study finds high-throughput sequencing bests flow cytometry
A study led by researchers at Fred Hutchinson Cancer Research Center has found that a next-generation, high-speed DNA-decoding technology called high-throughput sequencing can detect the earliest signs of potential relapse ...
Cancer
May 16, 2012 |
not rated yet |
0
|
T cell-based HIV gene therapy safe over long term
(HealthDay) -- T cell-based gene therapy for HIV seems safe, with no evidence of vector-induced cell immortalization more than a decade after treatment, according to a study published in the May 2 issue of ...
HIV & AIDS
May 07, 2012 |
5 / 5 (1) |
0
|
Genetically modified T cell therapy shown to be safe, lasting in decade-long study of HIV patients
HIV patients treated with genetically modified T cells remain healthy up to 11 years after initial therapy, researchers from the Perelman School of Medicine at the University of Pennsylvania report in the new issue of Science Tr ...
HIV & AIDS
May 02, 2012 |
5 / 5 (1) |
0
Two-faced leukemia?
One kind of leukemia sometimes masquerades as another, according to a study published online this week in the Journal of Experimental Medicine.
Cancer
Dec 12, 2011 |
5 / 5 (4) |
0
